156 related articles for article (PubMed ID: 34304559)
1. Synthesis and Preclinical Validation of Novel Indole Derivatives as a GPR17 Agonist for Glioblastoma Treatment.
Nguyen P; Doan P; Rimpilainen T; Konda Mani S; Murugesan A; Yli-Harja O; Candeias NR; Kandhavelu M
J Med Chem; 2021 Aug; 64(15):10908-10918. PubMed ID: 34304559
[TBL] [Abstract][Full Text] [Related]
2. GPR17 signaling activation by CHBC agonist induced cell death via modulation of MAPK pathway in glioblastoma.
Nguyen P; Doan P; Murugesan A; Ramesh T; Rimpilainen T; Candeias NR; Yli-Harja O; Kandhavelu M
Life Sci; 2022 Feb; 291():120307. PubMed ID: 35016881
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway.
Szeliga M; Karpińska M; Rola R; Niewiadomy A
Bioorg Chem; 2020 Dec; 105():104362. PubMed ID: 33074121
[TBL] [Abstract][Full Text] [Related]
4. PARP inhibitor cyanine dye conjugate with enhanced cytotoxic and antiproliferative activity in patient derived glioblastoma cell lines.
Choi PJ; Cooper E; Schweder P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; Park TI; Jose J
Bioorg Med Chem Lett; 2020 Jul; 30(14):127252. PubMed ID: 32527552
[TBL] [Abstract][Full Text] [Related]
5. 3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17.
Baqi Y; Pillaiyar T; Abdelrahman A; Kaufmann O; Alshaibani S; Rafehi M; Ghasimi S; Akkari R; Ritter K; Simon K; Spinrath A; Kostenis E; Zhao Q; Köse M; Namasivayam V; Müller CE
J Med Chem; 2018 Sep; 61(18):8136-8154. PubMed ID: 30048589
[TBL] [Abstract][Full Text] [Related]
6. Identification of imidazo[4,5-c]pyridin-2-one derivatives as novel Src family kinase inhibitors against glioblastoma.
Zhang L; Yang Z; Sang H; Jiang Y; Zhou M; Huang C; Huang C; Wu X; Zhang T; Zhang X; Wan S; Zhang J
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1541-1552. PubMed ID: 34238111
[TBL] [Abstract][Full Text] [Related]
7. Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma.
Nepali K; Hsu TI; Hsieh CM; Lo WL; Lai MJ; Hsu KC; Lin TE; Chuang JY; Liou JP
Eur J Med Chem; 2021 May; 217():113338. PubMed ID: 33744690
[TBL] [Abstract][Full Text] [Related]
8. Examination of sulfonamide-based inhibitors of MMP3 using the conditioned media of invasive glioma cells.
Poole AT; Sitko CA; Le C; Naus CC; Hill BM; Bushnell EAC; Chen VC
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):672-681. PubMed ID: 32156166
[TBL] [Abstract][Full Text] [Related]
9. Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells.
Sherer C; Tolaymat I; Rowther F; Warr T; Snape TJ
Bioorg Med Chem Lett; 2017 Apr; 27(7):1561-1565. PubMed ID: 28256372
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic analysis of glioblastoma multiforme providing new insights into GPR17 signaling communication.
Mutharasu G; Murugesan A; Konda Mani S; Yli-Harja O; Kandhavelu M
J Biomol Struct Dyn; 2022 Apr; 40(6):2586-2599. PubMed ID: 33140689
[TBL] [Abstract][Full Text] [Related]
11. A dual aurora and lim kinase inhibitor reduces glioblastoma proliferation and invasion.
Rybin MJ; Laverde-Paz MJ; Suter RK; Affer M; Ayad NG; Feng Y; Zeier Z
Bioorg Med Chem Lett; 2022 Apr; 61():128614. PubMed ID: 35151865
[TBL] [Abstract][Full Text] [Related]
12. The Orphan G Protein-coupled Receptor GPR17 Negatively Regulates Oligodendrocyte Differentiation via Gαi/o and Its Downstream Effector Molecules.
Simon K; Hennen S; Merten N; Blättermann S; Gillard M; Kostenis E; Gomeza J
J Biol Chem; 2016 Jan; 291(2):705-18. PubMed ID: 26620557
[TBL] [Abstract][Full Text] [Related]
13. Novel piperazine based benzamide derivatives as potential anti-glioblastoma agents inhibiting cell proliferation and cell cycle progression.
Lu Y; Feng Y; Li Z; Li J; Zhang H; Hu X; Jiang W; Shi T; Wang Z
Eur J Med Chem; 2022 Jan; 227():113908. PubMed ID: 34656900
[TBL] [Abstract][Full Text] [Related]
14. Structures/cytotoxicity/selectivity relationship of natural steroidal saponins against GSCs and primary mechanism of tribulosaponin A.
Dai Z; Liu H; Wang B; Yang D; Zhu YY; Yan H; Zhu PF; Liu YP; Chen HC; Zhao YL; Zhao LX; Zhao XD; Liu HY; Luo XD
Eur J Med Chem; 2021 Jan; 210():113068. PubMed ID: 33310292
[TBL] [Abstract][Full Text] [Related]
15. Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
Costa B; Bendinelli S; Gabelloni P; Da Pozzo E; Daniele S; Scatena F; Vanacore R; Campiglia P; Bertamino A; Gomez-Monterrey I; Sorriento D; Del Giudice C; Iaccarino G; Novellino E; Martini C
PLoS One; 2013; 8(8):e72281. PubMed ID: 23977270
[TBL] [Abstract][Full Text] [Related]
16. Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization.
Wang SY; Liu X; Meng LW; Li MM; Li YR; Yu GX; Song J; Zhang HY; Chen P; Zhang SY; Hu T
Bioorg Med Chem Lett; 2021 Jul; 43():128095. PubMed ID: 33965530
[TBL] [Abstract][Full Text] [Related]
17. Modified carbazoles destabilize microtubules and kill glioblastoma multiform cells.
Diaz P; Horne E; Xu C; Hamel E; Wagenbach M; Petrov RR; Uhlenbruck B; Haas B; Hothi P; Wordeman L; Gussio R; Stella N
Eur J Med Chem; 2018 Nov; 159():74-89. PubMed ID: 30268825
[TBL] [Abstract][Full Text] [Related]
18. Combination of Salinomycin and AZD3463 Reveals Synergistic Effect on Reducing the Viability of T98G Glioblastoma Cells.
Asik A; Ay NPO; Bagca BG; Caglar HO; Gunduz C; Avci CB
Anticancer Agents Med Chem; 2020; 20(18):2267-2273. PubMed ID: 32698744
[TBL] [Abstract][Full Text] [Related]
19. Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist.
Hennen S; Wang H; Peters L; Merten N; Simon K; Spinrath A; Blättermann S; Akkari R; Schrage R; Schröder R; Schulz D; Vermeiren C; Zimmermann K; Kehraus S; Drewke C; Pfeifer A; König GM; Mohr K; Gillard M; Müller CE; Lu QR; Gomeza J; Kostenis E
Sci Signal; 2013 Oct; 6(298):ra93. PubMed ID: 24150254
[TBL] [Abstract][Full Text] [Related]
20. Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia.
Puxeddu M; Shen H; Bai R; Coluccia A; Bufano M; Nalli M; Sebastiani J; Brancaccio D; Da Pozzo E; Tremolanti C; Martini C; Orlando V; Biagioni S; Sinicropi MS; Ceramella J; Iacopetta D; Coluccia AML; Hamel E; Liu T; Silvestri R; La Regina G
Eur J Med Chem; 2021 Oct; 221():113532. PubMed ID: 34052717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
